Stressgen Biotechnologies Corporation
Victoria, BC
Company Overview
Stressgen is a public biopharmaceutical company focused on the development and commercialization of innovative stress protein- based immunotherapeutics. The Company is developing a broad range of products for the treatment of viral infections and related cancers, such as anal dysplasia, genital warts, cervical dysplasia and cervical cancer. In addition to targeting HPV-related diseases, the Company also has a program to evaluate stress protein fusions in hepatitis B and has initiated research studies to evaluate its heat shock protein technology in the treatment of several other indications such as HIV and herpes.
Stressgen is an internationally recognized supplier of research products used by scientists worldwide for the study of cellular stress, apoptosis, oxidative stress, and neurobiology.
Company Information
Physical Address
350-4243 Glanford Ave.
Victoria, BC V8Z 4B9
CA
Mailing Address
350-4243 Glanford Ave.
Victoria, BC V8Z 4B9
CA
Additional Details
Legal Name: Stressgen Biotechnologies Corporation
Number of Employees: 94
CA
Heat shock proteins, also known as stress proteins, are present in cells of all organisms from bacteria to mammals. Stressgen capitalizes upon the immunostimulatory powers of Hsp by fusing, or covalently linking, a stress protein with an antigen to create a single hybrid molecule designed to trigger the immune system to recognize that antigen. Scientists believe that the Hsp portion of the fusion molecule directs the molecule to antigen-presenting cells such as dendritic cells. This in turn generates a CD8+ CTL immune response against the antigen to which the Hsp is fused. CTLs are programmed to survey the body for the presence of diseased cells bearing the antigen and eradicate them, while bypassing normal cells. Since the targeting antigen can be chosen from a wide variety of sources, the spectrum of human disease that potentially can be treated by Hsp fusions technology is vast and encompasses infectious diseases and cancers.
Contacts
Jennifer Matterson
Title: Communications Co-Ordinator
Phone: Show phone
Fax: Show fax
Email: Show email
Donna Slade
Title: Director of Investor Relations
Area of Responsibility: Management Executive
Phone: Show phone
Fax: Show fax
Email: Show email
Daniel Korpolinski
Title: Chief Executive Officer
Area of Responsibility: Management Executive
Phone: Show phone
Fax: Show fax
Email: Show email
Donald Tartre
Title: Chief Financial Officer
Area of Responsibility: Finance/Accounting
Phone: Show phone
Fax: Show fax
Services
- Vaccine Development
Products
- Agrin Antibodies - 4
- Biopharmaceutical Products
- Cell Lysates - 2
- Estrogen/Progesterone Receptors - 2
- Heat Shock Protein Elisa Kits -3
- Laboratory Reagents
- Oxidative Stress Antibodies - 10
- Pcr Primer Pairs-8
- Research Kits - 6
- Secondary Antibodies - 14
- Signal Transduction Antibodies - 17
- Signal Transduction Proteins - 19
- Stress Protein Antibodies - 56
- Stress Proteins & Molecular Chaperones - 23
- Substrates - 5
- Svt Repicles - 9
- Thyroid Hormone Receptor Antibodies - 6
- Tissue Extracts - 4
- Vescular Trafficking Antibodies - 17
- Vt Supernatrants - 8
Additional Information
541710
6550-In Vitro Diagnostic Substances, Reagents, Test Kits and Sets, AN00-Medical
Algeria, Argentina, Australia, Austria, Belgium, Brazil, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Iran, Israel, Italy, Japan, Kenya, Korea, South, Kuwait, Luxembourg, Malaysia, Netherlands, New Zealand, Norway, Poland, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States, Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming
New Hampshire, New Mexico, South Dakota